Financial Statements · Financial Reporting
Swixx Biopharma OÜ
Official identifier 12741121Record date 31 Dec 2022
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Jan 2022
- Submitted date
- 2 Jun 2023
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Bilanss, detailne | Assets | 678,627 |
| Bilanss, detailne | Cash and cash equivalents | 127,791 |
| Bilanss, detailne | Current assets | 641,665 |
| Bilanss, detailne | Current liabilities | 373,271 |
| Bilanss, detailne | Equity | 305,356 |
| Bilanss, detailne | Share capital at nominal value | 2,500 |
| Bilanss, detailne | Non-current assets | 36,962 |
| Bilanss, detailne | Retained earnings (loss) from previous periods | 145,666 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -9,887 |
| Income statement scheme 1 | Labour costs | -1,726,606 |
| Income statement scheme 1 | Revenue | 2,988,612 |
| Income statement scheme 1 | Annual period profit / loss | 156,940 |
| Income statement scheme 1 | Operating profit (loss) | 156,927 |
| Income statement scheme 1 | Profit (loss) before income tax | 156,940 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 145,666 |
| Note: Labour costs | Employees | 20 |
| Note: Labour costs | Labour costs | 1,726,606 |
Linked company
Company: Swixx Biopharma OÜ